Indolequinone antitumor agents: reductive activation and eli...
[Naylor, Matthew A.; Swann, Elizabeth; Everett, Steven A.; Jaffar, Mohammed; Nolan, John; Robertson, Naomi; Lockyer, Stacey D.; Patel, Kantilal B.; Dennis, Madeleine F.; Stratford, Michael R. L.; Wardman, Peter; Adams, Gerald E.; Moody, Christopher J.; Stratford, Ian J. Journal of Medicinal Chemistry, 1998 , vol. 41, # 15 p. 2720 - 2731]
|
Indolequinone Antitumor Agents: Correlation between Quinone ...
[Beall, Howard D.; Winski, Shannon; Swann, Elizabeth; Hudnott, Anna R.; Cotterill, Ann S.; O'Sullivan, Noeleen; Green, Stephen J.; Bien, Richard; Siegel, David; Ross, David; Moody, Christopher J. Journal of Medicinal Chemistry, 1998 , vol. 41, # 24 p. 4755 - 4766]
|
1 H NMR studies on the reductively triggered release of hete...
[Ferrer, Sandra; Naughton, Declan P.; Threadgill, Michael D. Tetrahedron, 2003 , vol. 59, # 19 p. 3445 - 3454]
|
INDQ/NO, a bioreductively activated nitric oxide prodrug
[Sharma, Kavita; Iyer, Aishwarya; Sengupta, Kundan; Chakrapani, Harinath Organic Letters, 2013 , vol. 15, # 11 p. 2636 - 2639]
|
INDQ/NO, a bioreductively activated nitric oxide prodrug
[Sharma, Kavita; Iyer, Aishwarya; Sengupta, Kundan; Chakrapani, Harinath Organic Letters, 2013 , vol. 15, # 11 p. 2636 - 2639]
|